MX2012000123A - Variantes de hemaglutinina de la influenza porcina. - Google Patents

Variantes de hemaglutinina de la influenza porcina.

Info

Publication number
MX2012000123A
MX2012000123A MX2012000123A MX2012000123A MX2012000123A MX 2012000123 A MX2012000123 A MX 2012000123A MX 2012000123 A MX2012000123 A MX 2012000123A MX 2012000123 A MX2012000123 A MX 2012000123A MX 2012000123 A MX2012000123 A MX 2012000123A
Authority
MX
Mexico
Prior art keywords
influenza hemagglutinin
swine influenza
variants
hemagglutinin variants
swine
Prior art date
Application number
MX2012000123A
Other languages
English (en)
Inventor
Hong Jin
Original Assignee
Medimmune Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medimmune Llc filed Critical Medimmune Llc
Publication of MX2012000123A publication Critical patent/MX2012000123A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16171—Demonstrated in vivo effect

Abstract

Se proporcionan polipéptidos, polinucleótidos, métodos, composiciones, y vacunas que comprenden las variantes de hemaglutinina y neuraminidasa de la influenza.
MX2012000123A 2009-06-25 2010-06-24 Variantes de hemaglutinina de la influenza porcina. MX2012000123A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US22042609P 2009-06-25 2009-06-25
US22798609P 2009-07-23 2009-07-23
US23402109P 2009-08-14 2009-08-14
US25889009P 2009-11-06 2009-11-06
PCT/US2010/039826 WO2010151673A1 (en) 2009-06-25 2010-06-24 Swine influenza hemagglutinin variants

Publications (1)

Publication Number Publication Date
MX2012000123A true MX2012000123A (es) 2012-03-07

Family

ID=43386887

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012000123A MX2012000123A (es) 2009-06-25 2010-06-24 Variantes de hemaglutinina de la influenza porcina.

Country Status (13)

Country Link
US (2) US8088393B2 (es)
EP (1) EP2448598B1 (es)
JP (1) JP5745511B2 (es)
KR (1) KR20120101318A (es)
CN (1) CN102802666B (es)
AU (2) AU2010266078B2 (es)
BR (1) BRPI1014844A2 (es)
CA (1) CA2766377A1 (es)
MX (1) MX2012000123A (es)
NZ (2) NZ596823A (es)
RU (1) RU2560420C2 (es)
SG (2) SG10201403557QA (es)
WO (1) WO2010151673A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201403557QA (en) 2009-06-25 2014-10-30 Medimmune Llc Swine influenza hemagglutinin variants
SG11201401137TA (en) * 2011-10-07 2014-07-30 Medimmune Llc Influenza hemagglutinin variants
KR101315273B1 (ko) * 2012-10-29 2013-10-08 대한민국 강독화된 인플루엔자 바이러스 변이주
CN105120893B (zh) * 2012-12-03 2018-11-13 诺华股份有限公司 流感病毒重配
MY186389A (en) 2014-05-13 2021-07-22 Univ Pennsylvania Compositions comprising aav expressing dual antibody constructs and uses thereof
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
WO2016200543A2 (en) 2015-05-13 2016-12-15 The Trustees Of The University Of Pennsylvania Aav-mediated expression of anti-inluenza antibodies and methods of use thereof
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
RS65241B1 (sr) 2017-02-28 2024-03-29 Univ Pennsylvania Vektor adeno-asociranih virusa (aav) iz podgrupe f i njegove upotrebe
JOP20190200A1 (ar) 2017-02-28 2019-08-27 Univ Pennsylvania تركيبات نافعة في معالجة ضمور العضل النخاعي
SG11201907611WA (en) 2017-02-28 2019-09-27 Univ Pennsylvania Influenza vaccines based on aav vectors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5382425A (en) * 1992-01-13 1995-01-17 Syntro Corporation Recombinant swinepox virus
US7871626B2 (en) * 2005-08-04 2011-01-18 St. Jude Children's Research Hospital Modified influenza virus for monitoring and improving vaccine efficiency
JP5349049B2 (ja) * 2005-10-17 2013-11-20 メディミューン，エルエルシー インフルエンザウイルス製造用マルチプラスミド系
CN101983069B (zh) * 2006-08-09 2014-07-16 米迪缪尼有限公司 流感血凝素和神经氨酸酶变体
WO2008145129A2 (en) * 2007-05-31 2008-12-04 Statens Serum Institut Influenza vaccines
SG10201403557QA (en) 2009-06-25 2014-10-30 Medimmune Llc Swine influenza hemagglutinin variants

Also Published As

Publication number Publication date
CN102802666B (zh) 2015-06-03
CN102802666A (zh) 2012-11-28
JP2012531205A (ja) 2012-12-10
US20120244600A1 (en) 2012-09-27
EP2448598A1 (en) 2012-05-09
JP5745511B2 (ja) 2015-07-08
CA2766377A1 (en) 2010-12-29
KR20120101318A (ko) 2012-09-13
NZ596823A (en) 2013-11-29
RU2012102385A (ru) 2013-07-27
SG10201403557QA (en) 2014-10-30
RU2560420C2 (ru) 2015-08-20
SG176178A1 (en) 2011-12-29
EP2448598B1 (en) 2016-03-30
US8088393B2 (en) 2012-01-03
NZ617191A (en) 2015-06-26
US8715691B2 (en) 2014-05-06
AU2010266078B2 (en) 2014-08-14
WO2010151673A1 (en) 2010-12-29
BRPI1014844A2 (pt) 2019-09-24
US20110123559A1 (en) 2011-05-26
AU2010266078A1 (en) 2011-12-22
AU2014203458A1 (en) 2014-07-17
EP2448598A4 (en) 2013-10-23

Similar Documents

Publication Publication Date Title
MX2011000437A (es) Variantes de hemaglutinina y neuramnidasa de influenza.
MX2012000123A (es) Variantes de hemaglutinina de la influenza porcina.
WO2008021959A3 (en) Influenza hemagglutinin and neuraminidase variants
MX2021001053A (es) Vacunas contra virus de la influenza y sus usos.
IL231547B (en) Polypeptide of the chimeric hemagglutinin (ha) from an influenza virus, an immune composition containing it and its uses
EP1856271A4 (en) INFLUENZA HEMAGGLUTININE AND NEURAMINIDASE VARIANTS
HK1209646A1 (en) Nasal influenza vaccine composition
EP2758038A4 (en) NEW INFLUENZA HEMAGGLUTININ PROTEIN VACCINES
GB0810305D0 (en) Influenza vaccination
SI2185191T1 (sl) Cepiva proti influenci z majhnimi dodatki
IL213189A0 (en) Recombinant avian influenza vaccine and uses thereof
SG10201709806VA (en) Hemagglutinin polypeptides, and reagents and methods relating thereto
IL224022B (en) Thermally stable influenza vaccine
PL2358386T3 (pl) Zoptymalizowane szczepionki na grypę
HK1200845A1 (en) Influenza hemagglutinin variants
EP2595653A4 (en) INFLUENZA VACCINE
GB0918679D0 (en) Influenza vaccine
EP2640405A4 (en) TREATMENT AND / OR CHARACTERIZATION OF INFLUENZA; POLYPEPTIDES HA ADAPTED TO MAN
SG11201503229SA (en) Swine influenza hemagglutinin and neuraminidase variants
ZA201100962B (en) Influenza vaccines
MX343411B (es) Variantes de hemaglutinina y neuraminidasa de influenza.
EP2307036A4 (en) NEW PEPTIDE ADJUVANT FOR INFLUENZA VACCINATION
EP2097103A4 (en) VACCINE FORMULATIONS AGAINST INFLUENZA
EP2368899A4 (en) VACCINE AGAINST AVIAN INFLUENZA
PT2482845T (pt) Nova composição de vacina contra influenza

Legal Events

Date Code Title Description
FA Abandonment or withdrawal